LJHT
Laurie J. Hall Trustee Portfolio holdings
AUM
$302M
This Quarter Return
-1.8%
1 Year Return
+17.68%
3 Year Return
+82.52%
5 Year Return
+131.39%
10 Year Return
–
AUM
$305M
AUM Growth
+$305M
(-3.5%)
Cap. Flow
-$1.94M
Cap. Flow
% of AUM
-0.64%
Top 10 Holdings %
Top 10 Hldgs %
36.97%
Holding
264
New
2
Increased
27
Reduced
70
Closed
13
Top Buys
| 1 |
McCormick & Company Non-Voting
MKC
|
$1.11M |
| 2 |
RELX
RELX
|
$947K |
| 3 |
CVS Health
CVS
|
$515K |
| 4 |
UL Solutions
ULS
|
$251K |
| 5 |
Danaher
DHR
|
$244K |
Top Sells
| 1 |
Canadian National Railway
CNI
|
$847K |
| 2 |
Microsoft
MSFT
|
$494K |
| 3 |
Exxon Mobil
XOM
|
$407K |
| 4 |
Eli Lilly
LLY
|
$386K |
| 5 |
Bank of New York Mellon
BK
|
$353K |
Sector Composition
| 1 | Technology | 30.55% |
| 2 | Healthcare | 19.91% |
| 3 | Industrials | 15.25% |
| 4 | Consumer Staples | 8.6% |
| 5 | Financials | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
New York Times
NYT
$9.74B
| $3.76M | 1.23% |
72,130
-1,895
| -3% | -$98.7K |
|
27
Medtronic
MDT
$119B
| $3.62M | 1.19% |
45,350
+1,290
| +3% | +$103K |
|
|
28
McCormick & Company Non-Voting
MKC
$18.9B
| $3.49M | 1.14% |
45,725
+14,595
| +47% | +$1.11M |
|
29
Amazon
AMZN
$2.44T
| $3.23M | 1.06% |
14,730
| – | – |
|
|
30
RELX
RELX
$85.3B
| $3.12M | 1.02% |
68,740
+20,845
| +44% | +$947K |
|
31
Unilever
UL
$155B
| $2.95M | 0.97% |
51,995
-748
| -1% | -$42.4K |
|
32
Advanced Micro Devices
AMD
$264B
| $2.89M | 0.95% |
23,884
-750
| -3% | -$90.6K |
|
33
AbbVie
ABBV
$372B
| $2.76M | 0.9% |
15,510
-160
| -1% | -$28.4K |
|
|
34
UL Solutions
ULS
$12.7B
| $2.7M | 0.88% |
54,050
+5,040
| +10% | +$251K |
|
35
Novartis
NVS
$245B
| $2.65M | 0.87% |
27,215
-337
| -1% | -$32.8K |
|
36
Becton Dickinson
BDX
$55.3B
| $2.65M | 0.87% |
11,662
+375
| +3% | +$85.1K |
|
37
Air Products & Chemicals
APD
$65.5B
| $2.62M | 0.86% |
9,025
-300
| -3% | -$87K |
|
38
3M
MMM
$82.8B
| $2.61M | 0.86% |
20,193
-925
| -4% | -$119K |
|
39
SPDR S&P 500 ETF Trust
SPY
$658B
| $2.53M | 0.83% |
4,310
+15
| +0.3% | +$8.79K |
|
40
Merck
MRK
$210B
| $2.33M | 0.77% |
23,454
-630
| -3% | -$62.7K |
|
41
Morgan Stanley
MS
$240B
| $2.26M | 0.74% |
18,000
| – | – |
|
42
Sysco
SYY
$38.5B
| $2.25M | 0.74% |
29,408
-1,065
| -3% | -$81.4K |
|
43
Crown Holdings
CCK
$11.6B
| $2.1M | 0.69% |
25,425
+1,235
| +5% | +$102K |
|
44
Vertex Pharmaceuticals
VRTX
$100B
| $2.07M | 0.68% |
5,143
+383
| +8% | +$154K |
|
45
Veralto
VLTO
$26.4B
| $1.93M | 0.63% |
18,949
+1,738
| +10% | +$177K |
|
46
Parker-Hannifin
PH
$96.2B
| $1.93M | 0.63% |
3,033
| – | – |
|
47
Emerson Electric
EMR
$74.3B
| $1.86M | 0.61% |
14,976
-125
| -0.8% | -$15.5K |
|
48
iShares MSCI EAFE ETF
EFA
$66B
| $1.77M | 0.58% |
23,425
| – | – |
|
49
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $1.73M | 0.57% |
36,078
-110
| -0.3% | -$5.26K |
|
50
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.72M | 0.57% |
3,803
-75
| -2% | -$34K |
|